World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01218243
Date of registration: 08/10/2010
Primary sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Public title: An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia
Scientific title: An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia
Date of first enrolment: September 2010
Target sample size: 100
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01218243
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
China
Contacts
Name:   Zhishun Liu
Address: 
Telephone:
Email:
Affiliation:  Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences
Key inclusion & exclusion criteria

Inclusion Criteria:

- 50-70 years old

- Mild to moderate BPH evaluated by I-PSS

- Patients having urinary dysfunction more than 3 months

- Patients with stable life signs

- no use of a1 receptor blocker, 5a-reductase inhibitor or traditional Chinese medicine
for over 1 week

- Volunteer to join this research and sign the written informed consent prior to
receiving treatment

Exclusion Criteria:

- Urinary dysfunction caused by gonorrhea or urinary tract infection

- Oliguria and anuria caused by urinary calculi, prostate cancer, bladder tumor and
acute/chronic renal failure

- Urinary dysfunction caused by neurogenic bladder, bladder neck fibrotic and urethral
stricture

- Failure of invasive therapy for prostatic obstruction

- Injured local organs, muscle and nerve caused by pelvic operation or historical
trauma

- Upper urinary obstruction and hydrocele combined with damaged renal function due to
BPH diagnosed by B-ultrasound

- Patients who can't stick to treatment because of economic reason, far distance
between home and the hospital or difficult walking etc.



Age minimum: 50 Years
Age maximum: 70 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Benign Prostatic Hyperplasia (BPH)
Intervention(s)
Device: needle
Primary Outcome(s)
Change of International Prostate Symptom Score(IPSS) at the 6th Week Compared With Baseline(Per-protocol). [Time Frame: baseline and the 6th week]
Change of IPSS at the 6th Week Compared With Baseline(Intention to Treat) [Time Frame: baseline and the 6th week]
Secondary Outcome(s)
Change of Bladder Residual Urine at the 6th Week [Time Frame: baseline and the 6th week]
Change of International Prostate Symptom Score (IPSS) at the 18th Week [Time Frame: baseline and the 18th week]
Change of Maximum Urinary Flow Rate(Qmax)at the 6th Week [Time Frame: baseline and the 6th week]
Secondary ID(s)
2009S208
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history